|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.04 CAD | -20.00% |
|
-16.67% | +100.00% |
Genix Pharmaceuticals Corporation reported earnings results for the full year ended October 31, 2023. For the full year, the company reported revenue was CAD 0.012347 million. Net loss was CAD 4.4 million compared to CAD 1.07 million a year ago.
Basic loss per share from continuing operations was CAD 0.07 compared to CAD 0.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +100.00% | 2.15M | |
| +13.21% | 8.15B | |
| -0.47% | 7.23B | |
| +12.30% | 6.65B | |
| -6.99% | 3.72B | |
| -7.42% | 3.64B | |
| -4.78% | 1.31B | |
| +12.61% | 972M | |
| -43.48% | 863M | |
| -13.54% | 799M |
GENIX PHARMACEUTICALS CORPORATION 
